Patient Safety Movement Foundation

1. The Frame

What people think this is about: A dedicated nonprofit founded by medical device entrepreneur Joe Kiani to eliminate the estimated 200,000+ preventable U.S. hospital deaths annually (and millions worldwide) through summits, free evidence-based safety protocols, hospital commitments to “zero harm,” and pushes for data transparency and aligned incentives.^[1]

What the machinery is actually doing: A small, founder-led nonprofit (PSMF) that amplifies Kiani’s personal brand and technologist worldview—prioritizing measurable practices, device data sharing, and policy access—while drawing funding from corporate-adjacent and foundation sources and operating in the shadow of Kiani’s 2024 ouster from Masimo after a bruising activist proxy fight.^[2]

2. Observations

• PSMF’s scale is modest: recent IRS data shows ~$365k–$717k in annual contributions/revenue, expenses often exceeding that, and assets under $100k in the latest filings, with a handful of staff. It punches above its weight via Kiani’s network and annual high-profile summits (12th held in early 2026 featuring Jill Biden).^[3]

• Claims of lives saved (hundreds of thousands cumulatively via hospital commitments and APSS implementation) are self-reported and not independently audited in public sources; some hospitals (e.g., Rady Children’s) cite zero preventable deaths after adopting practices, but broader outcome data remains sparse.^[2]

• The “open data pledge” for medtech companies aligns incentives toward interoperability and predictive tools—core to Kiani’s Masimo background in pulse oximetry and monitoring—while hospitals face pressure for transparency that could affect reimbursement and liability.

• Kiani’s 2021–2023 PCAST role produced a report highlighting 1-in-4 Medicare adverse events; the foundation continues promoting its recommendations post his Masimo departure, turning personal/policy influence into ongoing platform.^[4]

• An older (2014) ProPublica/NPR report flagged FDA concerns over Masimo’s complaint-handling processes around the time PSMF launched, illustrating the recurring tension between a founder’s safety advocacy and his company’s regulatory record.^[5]

• PSMF explicitly opposes criminal prosecution of individual medical errors (e.g., the 2022 RaDonda Vaught case), arguing it chills reporting and systemic fixes—a stance that prioritizes organizational “just culture” over personal accountability.

3. Snapshot

Founded in 2012 by Joe Kiani (Masimo founder) as a 501(c)(3) to drive “zero preventable deaths” by 2030, PSMF runs annual global summits, develops free Actionable Evidence-Based Practices (APSS), solicits hospital commitments and tech data pledges, and has influenced policy via Kiani’s Biden-era PCAST appointment. The 12th summit occurred in February/March 2026. Kiani stepped down from Masimo leadership in 2024 following Politan Capital’s successful proxy campaign.^[2]

4. Timeline of material facts

• 2012: Kiani founds PSMF.^[1]
• Jan 2013: First summit (keynote: President Clinton).^[1]
• 2014: ProPublica reports FDA warning letter to Masimo on complaint investigations.^[5]
• 2021: Kiani appointed to Biden’s PCAST.^[1]
• 2023: PCAST patient safety report released (co-led by Kiani); PSMF continues APSS work.^[4]
• 2023–2024: Politan Capital wins board seats; Kiani loses board seat and resigns as Masimo CEO/Chairman (Sept 2024).^[6]
• Feb/Mar 2026: 12th annual summit held.^[2]

5. Sides

PSMF / Kiani (technologist / patient-safety advocate, IT/LT mix): Best case—engineer applies rigorous, measurable practices and data transparency to a known problem (preventable harm); convenes stakeholders, provides free tools, secures high-level policy attention, and demonstrates results in committed sites. Sources: PSMF site, PCAST report, summit coverage.

Critique: LT — summits and APSS exist and some hospitals report gains. IT — founder’s device-company history and data-pledge emphasis create alignment questions; impact metrics self-reported; small org size limits independent verification.

Hospitals / payers / regulators: Steelmans implementation of evidence-based bundles and transparency mandates to reduce harm and costs; critique notes variable adoption and measurement challenges.

Activist investors / governance reformers (e.g., Politan context): Prioritize shareholder returns and accountability over founder entrenchment; the Masimo battle highlighted governance concerns but did not directly target PSMF.^[6]

6. Rumsfeld Matrix

• Known Knowns: Preventable harm exists at scale (IT per multiple studies); PSMF exists, runs summits, publishes APSS, and Kiani had PCAST role (LT).
• Known Unknowns: Independent, longitudinal outcome data on APSS-driven reductions across committed hospitals; precise attribution of “lives saved” claims.
• Unknown Knowns: Internal hospital data on error rates before/after commitments; full details of PSMF funding flows beyond public 990s.
• Unknown Unknowns: Whether broader adoption of the foundation’s model would shift systemic incentives enough to move national statistics meaningfully, or whether regulatory/cultural barriers dominate.

7. Incentives map

Kiani gains continued status, policy access, and platform after corporate exit. Hospitals gain liability shields, quality metrics, and potential reimbursement advantages from visible commitments. Medtech firms (via data pledges) gain pathways for connected devices and algorithms. Media and events benefit from high-profile speakers and “zero harm” framing. Bureaucracy self-perpetuation is limited by the org’s small size. Engagement/fear narratives around medical errors sustain attention.

8. Dueling AI advice

Moral AI Advice: Focus on verifiable implementation and transparent outcome tracking rather than aspirational targets. Align hospital bonuses and payer rules with actual harm reduction; treat data sharing as a tool, not a slogan. Founder-led nonprofits can drive focus but require scrutiny on metrics and conflicts.

Evil AI Advice: Brand the foundation as the indispensable “zero” movement, harvest summit photos with politicians, push pledges that favor your ecosystem’s devices, and keep the death-count narrative evergreen to maintain relevance and donor flow—accountability is for the little people.

9. Practical takeaway

• Track whether post-2024 independent evaluations of APSS outcomes emerge.
• Distinguish self-reported commitments from audited results.
• Watch hospital adoption tied to payment or accreditation incentives.
• Note any continued policy influence from Kiani or PSMF board alumni.
• Verify funding sources beyond headline grants when assessing independence.
• Compare PSMF’s “zero” framing against incremental, data-driven safety improvements elsewhere.

10. What would falsify this read

• Publication of rigorous, third-party longitudinal studies showing large, sustained reductions in preventable deaths directly attributable to PSMF APSS across dozens of hospitals.
• Major new independent funding or governance changes that sever ties to founder networks.
• Evidence that data-pledge signatories systematically blocked interoperability or that PSMF opposed transparency measures.
• Sharp decline in summit participation or hospital commitments post-Kiani’s Masimo exit.